Showing results (1611-1620 of 9,903) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|November 1, 1988
Irradiated donor buffy coat following T cell-depleted bone marrow transplantsA Gratwohl, A Tichelli, A Würsch, et al.Bone Marrow Transplantation|November 1, 1988
Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantationL Giannone, J A Whitlock, M C Kinney, et al.Bone Marrow Transplantation|July 9, 2021
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignanciesFei-Fei Tang, Xiang-Yu Zhao, Ming-Rui Huo, et al.Bone Marrow Transplantation|July 10, 2021
Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndromeRachel Bortnick, Marcin Wlodarski, Valerie de Haas, et al.Bone Marrow Transplantation|July 4, 2021
Steroid-refractory chronic graft-versus-host disease: treatment options and patient managementDaniel Wolff, Giancarlo Fatobene, Vanderson Rocha, et al.Bone Marrow Transplantation|July 17, 2021
Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remissionTakaaki Konuma, Tadakazu Kondo, Masayoshi Masuko, et al.Bone Marrow Transplantation|July 18, 2021
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantationAndrius Zucenka, Vilmante Vaitekenaite, Kazimieras Maneikis, et al.Bone Marrow Transplantation|July 18, 2021
Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional studyD M Greenfield, N Salooja, C Peczynski, et al.Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.Bone Marrow Transplantation|July 13, 2021
Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantationThomas Luft, Peter Dreger, Aleksandar RadujkovicPageof 991